首页> 外文会议>World congress on medical physics and biomedical engineering;International congress of the IUPESM >Radiosensitizing Effect of IUdR Combined with Co-60 y Radiation on MalignantGlioma Spheroids
【24h】

Radiosensitizing Effect of IUdR Combined with Co-60 y Radiation on MalignantGlioma Spheroids

机译:IUdR联合Co 60 y辐射对恶性肿瘤的放射增敏作用胶质瘤球

获取原文

摘要

Glioma is recognized as one of the most common tumors in the central nervous system. This tumor is resistant to all usual treatments. Because of the anatomical positions of this tumor, the surgery, as a treatment modality, is not possible in all cases. Even in the cases suitable for the surgery, because of the indistinct boundaries of this tumor and normal cells, complete elimination of the tumor is impossible. Glioma cells are also resistant to cytotoxic drugs. So, chemotherapy, as another treatment modality has no effect on this tumor. Sufficient radiation doses to kill the tumor cancer cells are not endurable for normal cells. Therefore, investigators are looking for new approaches to treat this malignant disease. One of the approaches is to use radiosensitizers in combination with the radiotherapy. IUdR is a halogenated pyrimidine which its radiosensitizing effect has been proved. In this research we have studied the effect of IUdR combined with 60Co y radiation for two sizes of Glioma spheroids (100 and 300u.m). The spheroid diameters were measured and analyzed to evaluate the level of radiation damages. Our results showed that the combination of IUdR with the 60Co y radiation can increase the radiation damage in both sizes of Glioma spheroids. The induced radiation damage in the greater spheroids was less than the lesser ones. This may be explained by the more hypoxic cells normally existed in greater spheroids. In addition, in greater spheroids more cells are in the GO phase of the cell cycle and cannot uptake IUdR, so they will not be affected by the sensitizing effect of this radiosensitizer.
机译:胶质瘤被认为是中枢神经系统中最常见的肿瘤之一。该肿瘤对所有常规治疗均具有抵抗力。由于该肿瘤的解剖位置,不可能在所有情况下都将手术作为一种治疗方式。即使在适合手术的情况下,由于该肿瘤与正常细胞之间的界限不清楚,因此不可能完全消除肿瘤。胶质瘤细胞也对细胞毒性药物具有抗性。因此,化学疗法作为另一种治疗方式对该肿瘤没有影响。足够的辐射剂量来杀死肿瘤癌细胞对于正常细胞是不能忍受的。因此,研究人员正在寻找治疗这种恶性疾病的新方法。方法之一是将放射增敏剂与放射疗法结合使用。 IUdR是卤代嘧啶,已证明其放射增敏作用。在这项研究中,我们研究了IUdR结合60Co y辐射对两种大小的胶质瘤球体(100和300u.m)的影响。测量和分析球体直径,以评估辐射损伤的程度。我们的结果表明,IUdR与60Co y辐射的结合可以增加两种胶质瘤球体的辐射损伤。大球体的辐射损伤小于小球体。这可能是由于通常存在于较大球体中的缺氧细胞更多。另外,在更大的球体中,更多的细胞处于细胞周期的GO期,不能摄取IUdR,因此它们不会受到这种放射增敏剂的增敏作用的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号